These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 34553745)
1. Ferroptosis-related lncRNA pairs to predict the clinical outcome and molecular characteristics of pancreatic ductal adenocarcinoma. Tang R; Wu Z; Rong Z; Xu J; Wang W; Zhang B; Yu X; Shi S Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34553745 [TBL] [Abstract][Full Text] [Related]
2. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K Front Immunol; 2021; 12():800268. PubMed ID: 34956238 [TBL] [Abstract][Full Text] [Related]
4. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma. Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017 [TBL] [Abstract][Full Text] [Related]
5. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment. Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X Front Immunol; 2022; 13():903758. PubMed ID: 36016939 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694 [TBL] [Abstract][Full Text] [Related]
7. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma. Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y Front Immunol; 2022; 13():970588. PubMed ID: 36148233 [TBL] [Abstract][Full Text] [Related]
8. Prognostic signature based on m6A-related lncRNAs to predict overall survival in pancreatic ductal adenocarcinoma. Wu Q; Chen L; Miao D; Jin Y; Zhu Z Sci Rep; 2022 Feb; 12(1):3079. PubMed ID: 35197523 [TBL] [Abstract][Full Text] [Related]
9. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs: role and contribution in pancreatic cancer. Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896 [TBL] [Abstract][Full Text] [Related]
11. Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma. Yang C; Dong Q; Bao H; Ge Y; Xu Z; Li J; Jiang X; Xu Y; Zhong X Front Biosci (Landmark Ed); 2024 Jan; 29(1):45. PubMed ID: 38287825 [TBL] [Abstract][Full Text] [Related]
12. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related]
14. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance. Jiang XY; Zhu QC; Zhang XJ; Duan T; Feng J; Sui XB; Sun XN; Mou YP Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):128-139. PubMed ID: 36543619 [TBL] [Abstract][Full Text] [Related]
15. lncRNA Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555 [TBL] [Abstract][Full Text] [Related]
16. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848 [TBL] [Abstract][Full Text] [Related]
17. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540 [TBL] [Abstract][Full Text] [Related]
18. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response. Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909 [TBL] [Abstract][Full Text] [Related]
19. Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. Zheng Y; Wu S; Huang X; Luo L Oxid Med Cell Longev; 2023; 2023():9598783. PubMed ID: 37251440 [TBL] [Abstract][Full Text] [Related]
20. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma. Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]